Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 158, Issue 2, 2011, Pages 338-342

  Paek, Jiheum ^a   Lee, San Hui ^a   Yim, Ga Won ^a   Lee, Maria ^a   Kim, Young Jae ^b   Nam, Eun Ji ^a   Kim, Sang Wun ^a   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

Epithelial ovarian cancer; HE4 protein; Survival

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; HUMAN EPIDIDYMIS PROTEIN 4; PACLITAXEL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; EPITHELIAL OVARIAN CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL;

EID: 80053570993     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.05.021     Document Type: Article

References (26)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 4 2009 225 249
2. G.D Malkasian, R.C. Knapp, and P.T. Lavin Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease Am J Obstet Gynecol 159 2 1988 341 346
3. I. Jacobs, and R.C. Bast Jr. The CA 125 tumour-associated antigen: a review of the literature Hum Reprod 4 1 1989 1 12 (Pubitemid 19069900)
4. M.L. Friedlander Prognostic factors in ovarian cancer Semin Oncol 25 3 1998 305 314 (Pubitemid 28272604)
5. K. Wang, L. Gan, and E. Jeffery Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray Gene 229 1-2 1999 101 108 (Pubitemid 29148312)
6. M.T. Galgano, G.M. Hampton, and H.F. Frierson Comprehensive analysis of HE4 expression in normal and malignant human tissues Mod Pathol 19 6 2006 847 853 (Pubitemid 43780455)
7. C.D. Hough, C.A. Sherman-Baust, and E.S. Pizer Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer Cancer Res 60 22 2000 6281 6287
8. C.D. Hough, K.R. Cho, A.B. Zonderman, D.R. Schwartz, and P.J. Morin Coordinately up-regulated genes in ovarian cancer Cancer Res 61 10 2001 3869 3876 (Pubitemid 32720943)
9. R. Drapkin, H.H. von Horsten, and Y. Lin Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas Cancer Res 65 6 2005 2162 2169 (Pubitemid 40490123)
10. I. Hellstrm, J. Raycraft, and M. Hayden-Ledbetter The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Res 63 13 2003 3695 3700 (Pubitemid 36793054)
11. R.G. Moore, A.K. Brown, and M.C. Miller The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass Gynecol Oncol 108 2 2008 402 408 (Pubitemid 351174295)
12. N. Scholler, N. Fu, and Y. Yang Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc Natl Acad Sci USA 96 20 1999 11531 11536 (Pubitemid 29487415)
13. S.C. Mok, J. Chao, and S. Skates Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology J Natl Cancer Inst 93 19 2001 1458 1464 (Pubitemid 32982674)
14. J.H. Kim, S.J. Skates, and T. Uede Osteopontin as a potential diagnostic biomarker for ovarian cancer JAMA 287 13 2002 1671 1679 (Pubitemid 34289219)
15. J. Hwang, S. Na, H. Lee, and D. Lee Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer J Gynecol Oncol 20 3 2009 169 175
16. E.P. Diamandis, G.M. Yousef, A.R. Soosaipillai, and P. Bunting Human kallikrein 6 (zyme/proteaseM/neurosin): a new serum biomarker of ovarian carcinoma Clin Biochem 33 7 2000 579 583 (Pubitemid 32012441)
17. A.T. Baron, J.M. Lafky, and C.H. Boardman Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 8 2 1999 129 137 (Pubitemid 29085379)
18. Y. Cho, D. Kim, J. Kim, Y. Kim, K. Kim, and J. Nam Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women Yonsei Med J 50 2 2009 266 272
19. J.Y. Kim, B. Bae, K.S. Kim, E. Shin, and K. Park Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma Cancer Res Treat 41 1 2009 29 35
20. C. Kirchhoff, I. Habben, R. Ivell, and N. Krull A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors Biol Reprod 45 2 1991 350 357
21. C. Kirchhoff Molecular characterization of epididymal proteins Rev Reprod 3 2 1998 86 95 (Pubitemid 28310280)
22. K. Huhtinen, P. Suvitie, and J. Hiissa Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Br J Cancer 100 8 2009 1315 1319
23. M.R. Andersen, B.A. Goff, and K.A. Lowe Use of a symptom index, CA125, and HE4 to predict ovarian cancer Gynecol Oncol 116 3 2010 378 383
24. K. Niwa, M. Itoh, and T. Murase Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance Br J Cancer 70 6 1994 1191 1197 (Pubitemid 24358962)
25. A.K. Sood, J.I. Sorosky, M. Dolan, B. Anderson, and R.E. Buller Distant metastases in ovarian cancer: association with p53 mutations Clin Cancer Res 5 9 1999 2485 2490 (Pubitemid 29437332)
26. E. Anastasi, G. Giovanna Marchei, V. Viggiani, G. Gennarini, L. Frati, and M.G. Reale HE4: a new potential early biomarker for the recurrence of ovarian cancer Tumour Biol 31 2 2010 113 119